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Abstract
A few studies indicate that women with prolonged time-to-pregnancy (TTP) have an increased risk of cardiovascular disease 
(CVD). This has not been studied in men. We evaluated CVD risk by self-reported TTP among parous women (n = 64,064) 
and men (n = 50,533) participating in the Norwegian Mother, Father and Child Cohort Study. TTP was categorized as 0–3 
(reference), 4–12 and > 12 months. CVD diagnosed between 2008 and 2017 were available from the national patient and 
general practitioner databases. Risk of CVD by TTP was estimated using Cox regression adjusting for baseline age, education, 
BMI, smoking, diabetes, and number of offspring in both sexes, and history of endometriosis, ovarian cysts, preterm birth 
and pre-eclampsia for women. Mean age was 33 for women and 35 for men at baseline (years). The rate of any CVD was 24 
per 1000 person years among women and 22 per 1000 person years among men. Longer TTP was associated with increased 
rate of CVD among women, with adjusted hazard ratios (HRs) of 1.07 (95% CI: 1.03, 1.09) for TTP 4–12 months and 1.14 
(1.08, 1.20) for TTP > 12 months. Among men, respective HRs for CVD were 1.06 (1.00, 1.10) for TTP 4–12 months and 
1.07 (1.01, 1.14) for TTP > 12 months. We observed sex-differences in the relationship with CVD subtypes but none were 
statistically significant. In conclusion, both men and women with a prolonged TTP had a small increased risk of CVD, clinical 
significance of which is unclear. Further studies are necessary to investigate in detail what underlying causes of prolonged 
TTP might be reflected in the increased risk of CVD. Longer follow-up is required to confirm these preliminary findings.
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Background
Between 10 and 15% of couples try for more than 12 months 
before they conceive, which is often used as a cut off to 
define subfertility [1, 2]. Subfertility may be an early marker 
of chronic diseases risk, including the risk of cardiovascu-
lar disease (CVD) [3]. Two previous studies examined pro-
longed time-to-pregnancy (TTP) and risk of CVD in women 
[4, 5], including a small (N = 744) retrospective study and a 
Swedish registry-based study (N = 863,324), both supporting 
an increased risk of CVD with prolonged TTP in women. In 
contrast to these two studies, a Danish registry-based study 
(n = 87,221) found no increased risk of CVD among women 
who were diagnosed with fertility problems or seeking fertil-
ity treatment [6]. None of these studies evaluated the rela-
tionship among men.
Any increased risk of CVD among people with subfertil-
ity might have various potential explanations. Underlying 
explanations that might be shared between the sexes include 
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sociodemographics (such age and education), psychosocial 
stress and other health related factors [such as smoking and 
body-mass index (BMI)] linked to subfertility and known 
to influence the risk of CVD [7–10]. Other sex-specific 
factors that might be associated with differences in CVD 
risk according to subfertility include sex-hormone levels, 
underlying disorders related to fertility potential, use of 
assisted reproductive technologies and pregnancy compli-
cations [11–15]. Specific disorders that contribute to sub-
fertility and an increased risk of CVD include polycystic 
ovarian syndrome (PCOS) [16, 17] and endometriosis [18] 
in women, and varicoceles in men [19–21]. The large pro-
portion of unexplained subfertility (20–30%) [1, 2], and the 
underdiagnosis of conditions contributing to fertility prob-
lems [22–24], highlight the value of looking further at the 
relationship between TTP and risk of CVD.
The objective of the current study was to examine the 
relationship between TTP and CVD in both men and women. 
This will determine if subfertile couples should be followed 
more closely for future CVD risk. The purpose of this study 
was not to disentangle what factor(s) related to subfertility 
might increase CVD risk, but to understand whether subfer-
tility may be a marker of future CVD risk in young adults 
who may benefit from earlier efforts of CVD detection and 
prevention.
Methods
The Norwegian mother, father and child cohort 
study
We studied women and men participating in the Norwe-
gian Mother, Father and Child Cohort Study (MoBa) [25]. 
MoBa recruited pregnant women (about 95,000) and their 
partners (about 75,000) across Norway between 1999 and 
2009. A written informed consent was obtained from all 
participants. The participation rate of pregnant women was 
41%. Information from participants was obtained through 
questionnaires at the time of recruitment and at regular 
follow-up intervals. We obtained information on deliveries 
from the birth registry and CVD events from the Norwegian 
patient registry (information available from 2008 onwards) 
and general practitioner data base (information available 
from 2006 onwards) [26]. For men and women participat-
ing in MoBa to be included in our analysis, we required that 
they had participated in the cohort with at least one planned 
pregnancy, had provided information on the TTP for at least 
one of these planned pregnancy, and that they were without 
reported CVD at baseline. Participants could have had other 
pregnancies that were not included in the cohort for which 
we did not know the TTP. We used self-reported infor-
mation in MoBa questionnaires and combined these with 
registrations in the patient and general practitioner database 
made prior to baseline to identify prevalent CVD. Cases of 
CVD in the patient and general practitioner databases were 
only available from 2006 and 2008, respectively. Baseline 
was defined as January 1st 2008 or the time of recruitment 
for those recruited after this time, since this was when the 
national patient registry was established. The Norwegian 
data inspectorate approved the data collection in MoBa. The 
current study was approved by the Regional Committee for 
Medical and Health Research Ethics of South/East Norway.
Time‑to‑pregnancy
At the time of recruitment, women were asked whether their 
current pregnancy was planned or not. If the pregnancy was 
planned, women were asked to indicate how many months 
they had regular intercourse without contraception before 
they became pregnant. The answer options were less than 
1 month, 1–2 months, and 3 months or more. If they had 
been trying for more than 3 months, they indicated the 
exact number of months. Based on this information, we cat-
egorized TTP as 0–3 months, 4–12 months and more than 
12 months. Pregnancies conceived by assisted reproductive 
technologies were given a TTP of more than 12 months. 
Women could participate in the cohort with more than 
one pregnancy, and the TTP was reported for each preg-
nancy included in the cohort. We therefore used the longest 
reported TTP as the exposure for women with more than one 
pregnancy. Men were not asked separately about TTP. The 
TTP reported by the women was assigned to their partners.
Cardiovascular disease
We used self-reported information in MoBa questionnaires 
and registrations in the patient and general practitioner 
database prior to baseline to identify prevalent CVD. Nota-
bly, cases of CVD in the patient and general practitioner 
databases were only available from 2006 and 2008, respec-
tively. At recruitment, participants self-reported hyperten-
sion, heart disease or other cardiovascular diseases. Incident 
cases were identified through the registries. Diagnoses in the 
patient registry are coded according to the international clas-
sification of diseases version 10 (ICD-10), while diagnoses 
in general practitioner database are coded according to the 
international classification of primary care version 2 (ICPC-
2). The main outcome was overall CVD. We also separately 
examined hypertensive disorders, ischemic heart disease, 
cerebrovascular disease, atrial fibrillation/flutter, atheroscle-
rosis and other CVD disorders. See supplementary material 
“Appendix 1” for details on the administrative codes used 
to define the CVD outcomes. We had follow-up informa-
tion on CVD available from the registries until December 
31st, 2017. Validations studies that have been conducted on 
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some of the more common diagnosis codes indicated a high 
accuracy of the registrations in the health registries [27–29].
Covariates
From the medical birth registry, information was available 
on age (continuous) and number of children (0, 1, 2, and 3 
or higher). We obtained self-reported information through 
questionnaires on educational level (less than high school, 
high school, up to four years of university and more than 
4 years of university), smoking status (never, former and 
current), body-mass index (weight in kg/height in  m2), 
and diabetes mellitus (yes versus no). For women, we also 
explored the role of pregnancy complications in previous 
pregnancies as recorded in the birth registry, including any 
history of a preterm birth (defined as < 37 gestational weeks) 
or pre-eclampsia in a prior pregnancy, and self-reported his-
tory of endometriosis (yes vs. no) and ovarian cysts (yes 
vs. no) obtained through questionnaires. These background 
characteristics were obtained at recruitment (in the middle 
of the index pregnancy). We therefore assume that the men 
and women did not substantially change their lifestyle, fin-
ish an ongoing education, or get a new diagnosis between 
when they started trying to conceive and the middle of the 
index pregnancy.
Statistical analysis
We described the risk of CVD according to TTP categories 
using Kaplan Meier plots. We examined the magnitude of 
the association between TTP and risk of CVD using Cox 
proportional hazards regression. Women and men free of 
CVD at baseline were followed from January 1st 2008 (or 
the date of recruitment for those recruited after this time) 
until their first registration of CVD, death from other causes 
or December 31st 2017 for those who were alive and not 
diagnosed with CVD. To evaluate the proportional haz-
ards assumption, we examined the Schoenfeld residuals. 
In multivariable analysis, we adjusted for age, education, 
BMI, smoking, diabetes and number of children. We fur-
ther adjusted for history of preterm birth, pre-eclampsia, 
endometriosis and ovarian cysts for women. Prolonged 
TTP is influenced by female fertility problems, male fer-
tility problems or a combination of the two. Couples also 
share a lifestyle which might influence their fertility. One 
important example is partners’ correlated BMI [30]. We 
therefore adjusted for partners characteristics as the expo-
sure is a couple level exposure, and shared behaviours 
may be associated with own CVD risk. The main analy-
ses examined overall CVD risk, while secondary analyses 
describe the risk of CVD subtypes. Missing information on 
covariates were imputed by chained equations. This multiple 
imputation approach assumes missing at random. Using a 
non-parametric bootstrapping test, we compared the associa-
tions in men and women. We conducted sensitivity analyses 
excluding couples who had conceived by assisted reproduc-
tive technologies. We also conducted a sensitivity analysis 
where we included men and women who did not plan their 
pregnancy in the reference category of TTP 0–3 months. We 
further evaluated the role of pregnancy planning by conduct-
ing a stratified analysis according to use of contraceptives in 
the 12 months prior to conception.
As TTP is a couple level exposure, it is difficult to dis-
tinguish whether female, male or joint factors contribute to 
a prolonged TTP. As we are considering TTP as a proxy 
for subfertility, a large number of women and men may be 
misclassified (i.e. they are not subfertile but their partner 
is). We therefore conducted sensitivity analyses randomly 
assigning 20, 40, 60 and 80 percent of individuals in the 
categories of prolonged TTP to be in the reference category 
(TTP 0–3 months). We did this random reassignment 1000 
times using bootstrapping.
All analyses were conducted using Stata version 15 
(Statacorp, Texas).
Results
MoBa includes 95,135 women and 75,073 men. After 
restricting to those with at least one planned pregnancy 
(about 80%) in MoBa, with information on TTP and who 
were alive and free of CVD at baseline (90% of men and 95% 
of women), 64,064 women and 50,533 men were included 
in analyses (Fig. 1). The number of couples available is the 
same as the number of men (n = 50,533). The greater num-
ber of women compared to men/couples is due to the fact 
that a lot of women participated in the cohort without their 
partner. No men participated in the cohort without their part-
ner. About 60% of couples conceived within 3 months, 27% 
between 4–12 months, and 12% after more than 12 months. 
The distribution of background characteristics is presented 
in Table 1. The average follow-up time was 8.9 years (range 
0.1–10.5 years). The age range at the end of follow-up was 
between 27 and 62 for women (mean 43), and between 28 
and 78 for men (mean 45).
The risk of overall CVD was 24 per 1000 person years 
for women and 22 per 1000 person years for men. The 
Kaplan Meier curve indicated a modest increased risk of 
CVD among women with prolonged TTP (Fig. 2). Similar 
observations were made in men (Fig. 2). For overall CVD, 
the adjusted hazard ratio (HR) was 1.07 (95% CI: 1.03, 1.09) 
for women with a TTP of 4–12 months and 1.14 (95% CI: 
1.08, 1.20) for women with a TTP of more than 12 months, 
compared to women who conceived within 0–3 months 
(Fig. 3; supplementary material “Appendix 2”). The results 
were slightly attenuated among women after adjustment for 
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pregnancy complications and underlying disorders (supple-
mentary material “Appendix 2”). The adjusted HR for over-
all CVD was 1.06 (95% CI: 1.00, 1.10) among men with a 
TTP 4–12 months and 1.07 (95% CI: 1.01, 1.14) among men 
with a TTP of more than 12 months (Fig. 3; supplementary 
material “Appendix 3”).
The risk of hypertensive disorders was increased both 
among women with TTP 4–12 (adjusted HR 1.08; 95% CI: 
0.99, 1.18) and TTP more than 12 months (adjusted HR 
1.25; 95% CI: 1.13, 1.29), compared to TTP 0–3 months 
(Fig. 3; supplementary material “Appendix 2”). There was 
no increased risk of hypertensive disorders associated with 
TTP among men (Fig. 3; supplementary material “Appen-
dix 3”). In women, there was also a tendency for an incresed 
risk of cerebrovascular disease, with an adjusted HR of 1.16 
(95% CI: 0.96, 1.41) with a TTP of 4–12 months and 1.13 
(95% CI: 0.87, 1.47) with a TTP of more than 12 months 
(Fig. 3; supplementary material “Appendix 2”). In men, there 
was weak evidence of an increased risk of ischemic heart 
disease with TTP more than 12 months, with an adjusted HR 
of 1.18 (95% CI: 0.97, 1.43) (Fig. 3; supplementary material 
“Appendix 3”). There was no statistical evidence of differ-
ences in the associations between the sexes from the boot-
strapping test (p values > 0.2). The only exception was the 
estimated association between TTP 4–12 months and risk 
of cerebrovascular disease (p value 0.05). The results were 
similar after excluding men and women who used assisted 
reproductive technologies. The results also did not change 
after additional adjustment for characteristics of the partner 
(supplementary material appendices 2 and 3).
We excluded women and men with unplanned index 
pregnancies from the main analysis as they lacked a reliable 
TTP. Individuals with unplanned pregnancies were younger, 
had a lower education, were more likely to smoke and were 
more likely to be first-time parents (supplementary material 
“Appendix 4”). Women but not men with unplanned preg-
nancies had an increased CVD risk (supplementary material 
“Appendix 5”). As a sensitivity analysis, we included indi-
viduals with unplanned pregnancies in the category with a 
TTP of 0–3 months, yielding similar results to the main anal-
ysis (supplementary material appendices 6 and 7). The rela-
tionship between TTP and CVD was similar among those 
who had and had not used contraceptives in the past year, the 
small numbers yielded imprecise estimates (supplementary 
material appendices 8 and 9). Based on information provided 
by women, we compared background characteristics in men 
(their respective partners) according to participation in the 
cohort. We found that men who participated in the cohort 
were younger, had a higher educational attainment, were 
less likely to smoke and more likely to have planned their 
pregnancy compared to men who did not participate (supple-
mentary material “Appendix 10”). Restricting the evaluation 
to CVD diagnosed in the specialist health-care services also 
Fig. 1  Illustration of the eligible 
study population Women parcipang in MoBa
(n= 95,135)
Women who had an esmate of 
me-to-pregnancy
(n=67,969)
Women who had a planned 
pregnancy
(n=69,277)
Women free of CVD at start of 
follow-up
(n=64,064)
Men parcipang in MoBa
(n= 75,073)
Men who had an esmate of 
me-to-pregnancy
(n=56,459)
Men who had a planned 
pregnancy
(n= 57,832)
Men free of CVD at start of 
follow-up
(n=50,533)
Women with informaon on 
pregnancy planning
(n=84,489)
Men with informaon on 
pregnancy planning
(n= 68,459)
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yielded similar findings (supplementary material appendices 
11 and 12).
Our sensitivity analyses randomly reassigning a pro-
portion of individuals in the categories of prolonged TTP 
to be in the reference group resulted in an attenuation of 
our findings (supplementary material “Appendix 13”). The 
attenuation of the findings increased with the increasing 
proportion of individuals who were reassigned (from 20 to 
80%).
Discussion
We observed an increased risk of overall CVD with pro-
longed TTP among both men and women. The magnitude 
of the relationship appeared greater among women, but 
this needs to be further explored in future studies. There 
were some notable differences in the relationship between 
TTP and CVD subgroups between the sexes. For example, 
women with a prolonged TTP had an increased risk of cer-
ebrovascular disease, while men with a prolonged TTP had 
an increased risk of ischemic heart disease. Despite the large 
study population, there was no strong statistical support for 
differences between the sexes. However, in this relatively 
young population, it is important to note that for both sexes 
the majority of overall CVD events were ‘other’ category 
(disorders other than hypertensive disorders, ischemic heart 
disease, cerebrovascular disease, atrial fibrillation/flutter or 
atherosclerosis). As this is the first examination of TTP and 
CVD risk in both sexes, our findings require replication. We 
note that TTP is a complex couple-level measure likely to 
reflect a broad range of underlying factors. We were not able 
to disentangle what specific aspects related to subfertility 
might be reflected in the increased risk of CVD with the 
information available in MoBa.
Strengths of our study include the sample size, our eval-
uation of men, the detailed information on potential con-
founders, and information on TTP for several pregnancies 
to increase the likelihood of capturing lifetime history of 
subfertility. This allowed us to evaluate CVD subtypes and 
to estimate the highest reported TTP for men and women 
who participated with more than one pregnancy. Information 
on most confounders was obtained through questionnaires, 
and some misclassification is expected.
Our study had has some limitations. The participation 
rate in MoBa was 41%. Selection into the cohort is influ-
enced by age, number of offspring, underlying diseases and 
other characteristics [31]. MoBa also only includes couples 
who conceived, and we could not evaluate the risk of CVD 
among men and women who did not conceive after trying for 
a long time. Both of these selection factors could have led us 
to underestimate the association between prolonged TTP and 
risk of CVD, if couples with more severe subfertility who 
did not conceive have a higher risk of CVD than those who 
conceive. Information on background characteristics was 
obtained at recruitment reflecting the status at the time of 
pregnancy. Therefore it is possible that these characteristics 
changed between the time that the couple started trying to 
Table 1  Distribution of background characteristics among eligible 






Age, mean(SD) 33.2 (4.7) 35.2 (5.3)
Education, N(%)
Less than high school 4096 (6.4) 4106 (8.1)
High school 17,927 (28.0) 18,821 (37.2)
Up to 4 years of college 26,663 (41.6) 14,034 (27.8)
More than 4 years of college 15,118 (23.6) 12,192 (24.1)
Missing 260 (0.4) 1380 (2.7)
BMI, mean(SD) 23.9 (4.0) 25.8 (3.2)
Missing, N(%) 1589 (2.5) 1753 (3.5)
Smoking, N(%)
Never 33,097 (51.7) 24,443 (48.4)
Former 16,982 (26.5) 11,256 (22.3)
Current 13,710 (21.4) 14,436 (28.6)
Missing 275 (0.4) 398 (0.8)
Self-reported diabetes mellitus, N(%)
No 63,709 (99.5) 50,145 (99.2)
Yes 355 (0.6) 388 (0.8)
Parity, N(%)
0 29,616 (46.2) 24,586 (48.7)
1 23,219 (36.2) 17,726 (35.1)
2 9099 (14.2) 6737 (13.3)
3 + 2130 (3.3) 1484 (2.9)
Endometriosis
No 62,990 (98.3) NA
Yes 1074 (1.7) NA
Ovarian cysts
No 60,280 (94.1) NA
Yes 3784 (5.9) NA
History of preterm birth, N(%)
No 61,169 (95.5) NA
Yes 2895 (4.5) NA
History of pre-eclampsia, N(%)
No 62,179 (97.1) NA
Yes 1885 (2.9) NA
Time-to-pregnancy, N(%)
0–3 38,691 (60.4) 30,979 (61.3)
4–12 17,510 (27.3) 13,518 (26.8)
More than 12 7863 (12.3) 6036 (11.9)
Use contraceptive in the past year, N(%)
No 22,401 (35.0) 17,191 (34.0)
Yes 41,663 (65.0) 33,342 (66.0)
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conceive and they became pregnant. Notably, age-adjusted 
estimates were generally similar to multivariable estimates. 
The patient (registration from 2008) and general (registra-
tion from 2006) practitioner databases did not cover the 
whole recruitment period of MoBa, and we may have missed 
some incident cases between recruitment and when the fol-
low-up from the registries started. We only had follow-up 
information available from the registries through December 
2017, which limited our power particularly for the analysis 
of CVD subgroups. The participants in this study were still 
relatively young at the end of follow-up. CVD at such a 
young age could be indicative of genetic abnormalities, and 
the subtypes of CVD that present at such a young age are 
more likely to be influenced by genetics [32]. It is also pos-
sible that infertility is caused by or indicates such underlying 
genetic abnormalities, and our results might therefore be 
influenced by genetic confounding. This could have led us 
to overestimate the association of interest. We used women´s 
Fig. 2  Kaplan Meier curves showing the risk of cardiovascular disease across time according to the categories of time-to-pregnancy
Fig. 3  Risk of cardiovascular disease according to time-to-preg-
nancy among women (n = 65,584) and men (m = 51,039). The refer-
ence group are those with a time-to-pregnancy of 3 months or less. 
Adjusted for age, education, smoking status, body-mass index, diabe-
tes mellitus and number of offspring
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report of TTP and assigned this to their partners. This could 
have introduced misclassification. However, as TTP is a cou-
ple-level measure of fertility problems, it is unlikely that we 
would have obtained a more accurate answer if we had asked 
the men directly. Any discrepancy in the longest reported 
TTP for partners participating in MoBa would have reflected 
a switch of partners.
Since we used TTP as a proxy for subfertility, and TTP is 
a couple level measure, we conducted a sensitivity analyses 
where we randomly reassigned a proportion of individuals 
in the two categories of prolonged TTP to be in the reference 
group. We did this because individuals may be assigned to 
prolonged TTP because of their partners’ subfertility. These 
sensitivity analyses indicated that any individual misclas-
sification due to the fact that TTP is a couple-level measure 
resulted in a modest overestimation of the associations. This 
challenge in the interpretation of associations of TTP with 
CVD has not been adequately discussed in previous papers.
Our study is in line with previous studies reporting an 
increased risk of CVD among women with prolonged TTP. 
A cross-sectional study of 744 U.S. women age 20–59 
reported a 1.83 times higher odds (95% CI: 1.15, 2.89) of 
heart failure, coronary heart disease, heart attack or stroke 
among women with a TTP > 12 months [4]. A Swedish reg-
istry-based study indicated an increased risk of coronary 
heart disease, stroke or heart failure among women who 
reported having tried for more than 5 years to conceived 
compared to those who conceived within the first year, with 
an adjusted HR of 1.19 (95% CI: 1.02, 1.39), while there 
was no increased risk among women who reported having 
tried for 1–2 (HR 1.07; 95% CI: 0.92, 1.23) or 3–4 years (HR 
1.01; 0.83, 1.23) [5]. The findings from these two studies 
contrast results from a Danish registry-based study report-
ing no increased risk of ischemic heart disease or cerebro-
vascular disease among women diagnosed with infertility, 
adjusted hazard ratio 0.98 (95% CI: 0.85, 1.14) [6]. The het-
erogeneity in the findings across studies is likely influenced 
by differences in the definition of subfertility or prolonged 
TTP, the CVD outcomes examined, and the age composition 
of the study populations.
Previous studies have not examined the relationship 
between prolonged TTP and risk of CVD in men. An 
increased risk of CVD is reported among both childless men 
and women [33–35]. However, the interpretation of these 
studies is difficult since childlessness can be voluntary. Our 
finding of a small increased CVD risk among men with 
prolonged TTP, as well as the possible greater risk among 
women than men would benefit from replication.
There may be differences in the relationships between 
TTP and CVD subtypes between the sexes, although our 
findings were inconclusive due to modest number of cases. 
Specifically, TTP was associated with a modest increased 
risk of cerebrovascular disease only in women, while an 
increased risk of ischemic heart disease according to pro-
longed TTP was only seen in men. CVD is more likely 
to first manifest as cerebrovascular disease in women and 
ischemic heart disease in men [36]. Based on what we know 
about the risk of CVD subtypes according to known CVD 
risk factors, cerebrovascular is more closely linked to hyper-
tension while ischemic heart disease is more linked to hyper-
cholesterolemia [37]. Our observation that the risk of hyper-
tensive disorders associated with TTP was only robustly 
evident among women and not men therefore corresponds 
well with an increased risk of cerebrovascular disease. Due 
to our limited follow-up time and the relatively young age of 
the participants at the end of follow-up, these relationships 
need to be further investigated.
A prolonged TTP is associated with greater risk of preg-
nancy complications [38, 39], and several pregnancy com-
plications are associated with increased risk of CVD among 
women [12]. Whether use of assisted reproductive technolo-
gies influences the risk of CVD in women remains unclear 
[13, 14]. Interestingly, accounting for women’s history of 
pregnancy complications, endometriosis, ovarian cysts and 
use of assisted reproductive technologies only slightly atten-
uated our findings. These findings highlight that there might 
be other aspects related to subfertility among women that 
warrant further investigation.
In conclusion, women and men with a prolonged TTP 
may have an increased risk of CVD. Our findings indicate 
that there may be differences in the risk of CVD subtypes 
associated with prolonged TTP between the sexes, although 
this needs to be further investigated. Further studies are also 
necessary to investigate in detail what underlying causes of 
prolonged TTP might be reflected in the increased risk of 
CVD.
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